Clinical Evaluation of Taurolidine‐Absorbed Gelatin Sponges in Wound Care: A Retrospective Pilot Study on Chronic Ulcers and Active‐Comparator Acute Wounds
International Wound Journal · 2026-11 · 23 (11)
DOI: 10.1111/iwj.71125 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Wound Journal, online erschienen am 20.11.2026. Verfasst von Ha Jong Nam und 3 weiteren Autor:innen. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Themen: Wundversorgung
Abstract (Originalsprache)
Chronic ulcers and split‐thickness skin graft donor sites require dressing strategies that stabilize the wound environment while minimizing bacterial burden, pain, dressing adherence, and delayed epithelialization. This retrospective pilot study evaluated the preliminary clinical outcomes and feasibility of taurolidine‐absorbed gelatin sponge dressing in chronic ulcers and acute donor‐site wounds. Forty‐five cases were reviewed. The chronic cohort included 33 chronic ulcers treated with taurolidine‐Cutanplast or saline‐Cutanplast after wound‐bed preparation. The acute cohort included 12 split‐thickness skin graft donor sites evaluated using an intra‐patient split‐wound comparison between taurolidine‐Cutanplast and collagen matrix. Clinical, microbiological, pain‐related, dressing‐related, and safety outcomes were analysed. In the chronic cohort, taurolidine‐Cutanplast showed greater granulation coverage at Day 14 than saline‐Cutanplast (78.6% ± 14.1% vs. 59.4% ± 16.8%; mean difference 19.20%, 95% CI 8.21–30.19; p = 0.001) and a higher wound area reduction rate (42.8% ± 15.6% vs. 27.3% ± 13.9%; mean difference 15.50%, 95% CI 4.98–26.02; p = 0.005). Day 7 bacterial burden was lower in the taurolidine‐Cutanplast group (3.1 ± 0.8 vs. 4.4 ± 0.9 log10 CFU/mL; mean difference −1.30, 95% CI −1.90 to −0.70; p < 0.001), with a higher frequency of ≥ 2‐log bacterial reduction (64.7% vs. 25.0%; risk ratio 2.59, 95% CI 1.03–6.48; p = 0.022). In the acute cohort, no statistically significant between‐area differences were observed in pain, re‐epithelialization time, dressing adherence, or minor bleeding. No severe material‐related adverse event was identified. Taurolidine‐absorbed gelatin sponge dressing showed favourable preliminary outcomes in chronic ulcers and acceptable short‐term safety and feasibility in donor‐site wounds. Prospective studies are needed to validate its role as a local adjunctive wound‐contact dressing.
Zitieren
APA
Nam, H. J., Kim, M. W., Jung, Y. H., & Choi, H. J. (2026). Clinical Evaluation of Taurolidine‐Absorbed Gelatin Sponges in Wound Care: A Retrospective Pilot Study on Chronic Ulcers and Active‐Comparator Acute Wounds. International Wound Journal, 23(11). https://doi.org/10.1111/iwj.71125
Vancouver
Nam HJ, Kim MW, Jung YH, Choi HJ. Clinical Evaluation of Taurolidine‐Absorbed Gelatin Sponges in Wound Care: A Retrospective Pilot Study on Chronic Ulcers and Active‐Comparator Acute Wounds. International Wound Journal. 2026;23(11). doi:10.1111/iwj.71125
BibTeX
@article{Nam2026,
author = {Nam, Ha Jong and Kim, Min Wook and Jung, Young Hyun and Choi, Hwan Jun},
title = {Clinical Evaluation of Taurolidine‐Absorbed Gelatin Sponges in Wound Care: A Retrospective Pilot Study on Chronic Ulcers and Active‐Comparator Acute Wounds},
journal = {International Wound Journal},
year = {2026},
volume = {23},
number = {11},
doi = {10.1111/iwj.71125}
}
EUVIMED